Covance Biotechnology Services Inc.

PositionTo be acquired by Akzo Nobel N.V. - Brief Article

CARY -- Princeton, N.J.-based Covance Inc. is selling its contract-manufacturing business, Covance Biotechnology Services Inc., for $190 million to a division of Akzo Nobel NV, a $13 billion Dutch manufacturer of drugs, paint and chemicals. Few layoffs are expected...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT